PaxMedica, Inc.
PXMD
$0.0001
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -46.22% | -13.55% | -32.03% | 2.45% | 256.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.70% | -8.58% | -11.88% | 61.95% | 262.08% |
| Operating Income | 10.70% | 8.58% | 11.88% | -61.95% | -262.08% |
| Income Before Tax | 14.01% | 3.66% | -13.41% | 55.95% | -18,448.95% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.01% | 3.66% | -13.41% | 55.95% | -18,448.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.01% | 3.66% | -13.41% | 55.95% | -18,448.95% |
| EBIT | 10.70% | 8.58% | 11.88% | -61.95% | -262.08% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 90.33% | 90.35% | 80.45% | 75.53% | -12,563.08% |
| Normalized Basic EPS | 90.33% | 90.25% | 78.65% | 77.08% | -611.52% |
| EPS Diluted | 90.33% | 90.31% | 80.44% | 75.51% | -12,563.08% |
| Normalized Diluted EPS | 90.33% | 90.25% | 78.65% | 77.08% | -611.52% |
| Average Basic Shares Outstanding | 789.45% | 897.89% | 480.02% | 79.98% | 111.63% |
| Average Diluted Shares Outstanding | 789.45% | 897.89% | 480.02% | 79.98% | 111.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |